CorMedix Inc. (CRMD) shares climbed 6.88 percent to $11.96 on Wednesday after the company reported a sharp turnaround to profit in the third quarter.
A year prior, the biopharmaceutical company reported a net loss of $2.8 million, or $0.05 per share, while this year it reported a net income of $108.6 million, or $1.26 per share. Due to a sharp increase in product sales to $101.5 million, revenue increased from $11.5 million to $104.3 million.
With a volume of 5.4 million shares, the stock fluctuated between $10.75 and $12.89 from its opening price of $11.75 to an average of 3.2 million shares on the Nasdaq. Over the previous 52 weeks, CorMedix has fluctuated between $5.60 and $17.43.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.